Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)

Publication | Closed Access

DOI

Citations

References

2008

Year

Gretchen Kimmick, Constance Cirrincione, David B. Duggan, Kapil N. Bhalla, Nicholas J. Robert, Don Berry, Larry Norton, Steffen Lemke, I. Craig Henderson, Clifford A. Hudis,

Breast Cancer Research and Treatment

Radiation MedicineSurgical OncologyPhase Ii TrialBreast OncologyMedicineNeoadjuvant DoxorubicinCalgb 8944Breast CancerCancer TreatmentBreast SurgeryOncologyRadiation OncologyRadiologyHealth Sciences